Key facts
- This page summarizes Natalie B. Lemoine's Form 4 filing for HOME BANCORP, INC. (HBCP).
- 1 reported transaction and 5 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2026, 16:54.
Natalie B. Lemoine - 12 Jun 2026 Form 4 Insider Report for HOME BANCORP, INC. (HBCP)
- Reporting relationship
- SEVP, Chief Admin. Officer
- Issuer ticker
- HBCP
- Reported as of
- 12 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Jun 2026, 16:54:47 UTC
- Prior SEC filing
- 18 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Natalie B. Lemoine
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Natalie B. Lemoine filed Form 4 for HOME BANCORP, INC. (HBCP) on 15 Jun 2026.
Change
- Previous filing in this sequence was filed on 18 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002030957
Primary reporting owner
Lemoine Natalie B.
- Relationship
- SEVP, Chief Admin. Officer
- Address
- 503 KALISTE SALOOM ROAD, LAFAYETTE
- Signature
- /s/ Natalie B. Lemoine
- Signature date
- 15 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HBCP
transaction
Common Stock
Award
- Transaction value
- Shares
- +100
- Change %
- +1.2%
- Price
- Shares after
- 8,214
- Date
- 12 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4, F5, F6
HBCP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,641
- Date
- 12 Jun 2026
- Ownership
- ESOP
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HBCP
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 400
- Date
- 12 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 400
- Exercise price
- $35.26
- Footnotes
- F7
HBCP
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500
- Date
- 12 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500
- Exercise price
- $45.12
- Footnotes
- F8
HBCP
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500
- Date
- 12 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500
- Exercise price
- $35.85
- Footnotes
- F9
HBCP
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500
- Date
- 12 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500
- Exercise price
- $21.99
- Footnotes
- F10
HBCP
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500
- Date
- 12 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500
- Exercise price
- $36.77
- Footnotes
- F11
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 11 footnotes
Footnote F1
Includes the grant of 100 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on June 12, 2027 and that may be settled only in shares of the Issuer's common stock.
Footnote F2
Includes the grant of 1250 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025, and that may be settled only in shares of the Issuer's common stock.
Footnote F3
Includes the grant of 1300 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2027 and that may be settled only in shares of the Issuer's common stock.
Footnote F4
Includes the grant of 1391 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2026, and that may be settled only in shares of the Issuer's common stock.
Footnote F5
Includes the grant of 750 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 450 restricted stock units remain unvested.
Footnote F6
Includes the grant of 800 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 640 restricted stock units remain unvested.
Footnote F7
The options vest and become exercisable in five equal installments beginning May 12, 2018.
Footnote F8
The options vest and become exercisable in five equal installments beginning May 23, 2019.
Footnote F9
The options vest and become exercisable in five equal installments beginning May 23, 2020
Footnote F10
The options vest and become exercisable in five equal installments beginning March 12, 2021.
Footnote F11
The options vest and become exercisable in five equal installments beginning May 12, 2022.